Company / Net Income
Altimmune, Inc. Net Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$88.1M
FY2025
5-year range
-$97.1M / -$49.0M
FY2021-FY2025
Trend
+0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$97M in FY2022 to -$11M in FY2017.
Based on SEC 10-K filings.
-$88M in FY2025.
Declined from -$85M to -$88M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 0.4% year-over-year.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$88.1M | +0.4% |
| FY2024 | -$88.4M | -4.4% |
| FY2023 | -$84.7M | +12.7% |
| FY2022 | -$97.1M | -98.0% |
| FY2021 | -$49.0M | -139.0% |
| FY2020 | -$20.5M | +47.6% |
| FY2019 | -$39.2M | +15.6% |
| FY2018 | -$46.4M | -318.7% |
| FY2017 | -$11.1M | +68.2% |
| FY2011 | -$34.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026